Filippo Mazzoni

Dr. Filippo Mazzoni

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
FBFilippo Besana
Filippo Besana
SCSerena Chiara Civardi
Serena Chiara Civardi
FMFilippo Mazzoni
Filippo Mazzoni
GMGiovanni Carnevale Miacca
Giovanni Carnevale Miacca
VAVincenzo Arienti
Vincenzo Arienti
Miriam OlivolaMiriam Olivola
Miriam Olivola
Background: A significant number of young individuals are readmitted one or more times shortly after their first episode of psychosis. Readmission may represent a marker of psychopathological vulnerability. Our primary aim was to evaluate the impact of clinical and socio-demographic variables on readmission at 12-month follow-up. Secondly, our goal was to determine whether the use of Long-Acting Injection (LAI) antipsychotics provides notable benefits compared to oral medications in preventing subsequent readmissions. Subjects and methods: 80 patients hospitalised for the first time with a diagnosis of psychotic disorder (ICD-10 criteria) were retrospectively assessed through clinical records. The mean age was 21.7 years. Patients were predominantly male (n = 62, 77.5%), and 55 subjects had at least 8 years of education. 50% of the sample was “NEET” (not in education, employment, or training). Results: 35 patients (43.8%) were discharged with a LAI antipsychotic, while 45 (56.2%) recieved oral antipsychotic therapy. Substance use (p = 0.04) and oral antipsychotics at discharge (p = 0.003) were significantly associated with readmission at 1 year. We did not find any significant predictors of being discharged with LAI therapy. Conclusion: Our findings underlined the importance of identifying patients at risk of readmission in order to prevent future rehospitalization and promote appropriate prevention strategies. LAIs should be considered as a first-choice treatment for patients hospitalised for FEP since they proved to be effective in preventing relapse.

17 April 2026 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
FRFabiola Raffone
Fabiola Raffone
FMFilippo Mazzoni
Filippo Mazzoni
ACArianna De Ciechi
Arianna De Ciechi
NGNicolaja Girone
Nicolaja Girone
MMMonica Macellaro
Monica Macellaro
VMVassilis Martiadis
Vassilis Martiadis

16 June 2026 in Psychiatry Research
Verified
Journal Article
Closed access
FMFilippo Mazzoni
Filippo Mazzoni
FRFabiola Raffone
Fabiola Raffone
ACArianna De Ciechi
Arianna De Ciechi
NGNicolaja Girone
Nicolaja Girone
MMMonica Macellaro
Monica Macellaro
Miriam OlivolaMiriam Olivola
Miriam Olivola